LAMA2-MD (MEROSIN DEFICIENT CONGENITAL MUSCULAR DYSTROPHY, MDC1A)
Clinical trials for LAMA2-MD (MEROSIN DEFICIENT CONGENITAL MUSCULAR DYSTROPHY, MDC1A) explained in plain language.
Never miss a new study
Get alerted when new LAMA2-MD (MEROSIN DEFICIENT CONGENITAL MUSCULAR DYSTROPHY, MDC1A) trials appear
Sign up with your email to follow new studies for LAMA2-MD (MEROSIN DEFICIENT CONGENITAL MUSCULAR DYSTROPHY, MDC1A), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
A protein clue in the fight against muscular dystrophy?
Knowledge-focused Recruiting nowThis study looks at whether levels of a protein called HMGB1 are different in people with LAMA2-related muscular dystrophy, a condition that causes severe muscle weakness. Researchers will measure HMGB1 in blood and muscle samples already collected from about 25 patients. The goa…
Matched conditions: LAMA2-MD (MEROSIN DEFICIENT CONGENITAL MUSCULAR DYSTROPHY, MDC1A)
Sponsor: IRCCS San Raffaele • Aim: Knowledge-focused
Last updated Aug 06, 2026 00:00 UTC
-
New study tracks toddlers with rare muscle disease to prep for future treatments
Knowledge-focused Recruiting nowThis study watches how children under 5 with LAMA2-related muscular dystrophy move and develop over two years. Researchers will test muscle function, swallowing, breathing, and collect blood samples. The goal is to learn more about the disease so future treatments can be tested e…
Matched conditions: LAMA2-MD (MEROSIN DEFICIENT CONGENITAL MUSCULAR DYSTROPHY, MDC1A)
Sponsor: Nationwide Children's Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:05 UTC